| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/31/2011 | CN101591691B High density fermentation culture medium of restructured human interferon alpha2b |
| 08/31/2011 | CN101418304B Method for preparing soluble E2 antigen for detecting swine fever virus serum antibody |
| 08/31/2011 | CN101367871B Snake venom protein component of ahylysantinfarctase at southern Anhui Province, extraction method and uses thereof |
| 08/31/2011 | CN101353377B Zone 1 protein of programmed cell death protein 2 analogue and uses thereof |
| 08/31/2011 | CN101353376B Protein related to rice ear sprouting period and encoding genes and uses thereof |
| 08/31/2011 | CN101348821B High purity sericin powder prepared from silkworm cocoon blaze and preparation thereof |
| 08/31/2011 | CN101193658B Pegylated G-CSF polypeptides and methods of producing same |
| 08/31/2011 | CN101173007B 1-amido-glycolyurea immunogen, producing method and application of the same |
| 08/30/2011 | US8008557 Inbred corn line NPJC7538 |
| 08/30/2011 | US8008556 Inbred corn line NPFX8091 |
| 08/30/2011 | US8008554 Inbred corn line NPID4789 |
| 08/30/2011 | US8008543 Modification of flavonoid biosynthesis in plants by PAP1 |
| 08/30/2011 | US8008470 Integrase cofactor |
| 08/30/2011 | US8008463 Polymorphic regulatory factor X-4 polypeptides for use as tools in detection and treatment of brain disorders |
| 08/30/2011 | US8008460 Polynucleotide fragments of an infectious human endogenous retrovirus |
| 08/30/2011 | US8008456 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses |
| 08/30/2011 | US8008451 Antibodies to TNF (tumor necrosis factor) receptor family members |
| 08/30/2011 | US8008450 Therapeutic use of anti-CS1 antibodies |
| 08/30/2011 | US8008439 casting an aqueous solution of silk fibroin and cellulose, chitin, chitosans, keratin from wool or polyvinyl alcohol on the surfaces of substrates, then drying the solution, to form composite films, used as metal ion adsorber materials, sustained release or biological cell-growth substrates |
| 08/30/2011 | US8008438 High affinity NY-ESO T cell receptors |
| 08/30/2011 | US8008437 Prostatic/ovarian tumor antigen for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 08/30/2011 | US8008436 Adenovirus 36 E4 orf 1 gene and protein and their uses |
| 08/30/2011 | US8008434 Preparation of solid phase bound peptides or PNAs |
| 08/30/2011 | US8008433 Methods for preventing or treating bone disorders |
| 08/30/2011 | US8008431 Tumor-associated peptides that bind to MHC-molecules |
| 08/30/2011 | US8008276 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 08/30/2011 | US8008266 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 08/30/2011 | US8008265 Vaccines, immunotherapeutics and methods for using the same |
| 08/30/2011 | US8008262 β-peptides |
| 08/30/2011 | US8008261 Methods of reducing trail-induced apoptosis by trail isoforms |
| 08/30/2011 | US8008257 ANF fusion proteins |
| 08/30/2011 | US8008255 Methods and compositions for enhanced transmucosal delivery of peptides and proteins |
| 08/30/2011 | US8008249 Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration |
| 08/30/2011 | US8008248 Modified Cry3A toxins and nucleic acid sequences coding therefor |
| 08/30/2011 | US8008074 Compositions and methods for improving bone mass through modulation of receptors of PTH and fragments thereof |
| 08/30/2011 | US8008071 Vector comprising first polynucleotide encoding glucose responsive mRNA instability element, second polynucleotide encoding reporter polypeptide and promoter sequence; fluorescence based high throughput screening |
| 08/30/2011 | US8008058 Ketose 3-epimerase, its preparation and uses |
| 08/30/2011 | US8008053 Allosteric control of proteins by manipulating mechanical tension |
| 08/30/2011 | US8008048 L-cysteine-producing bacterium and a method for producing L-cysteine |
| 08/30/2011 | US8008027 Methods of screening for compounds that modulate the activity of ADEC, a chemokine expressed in inflamed adenoid |
| 08/30/2011 | US8008023 Natural ligand of G protein coupled receptor RCC356 and uses thereof |
| 08/30/2011 | US8008000 Viral variants detection and application |
| 08/30/2011 | US8007997 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 08/30/2011 | US8007994 Using nuclear receptor to identify modulators for controlling intestinal cholesterol adsorption |
| 08/30/2011 | US8007813 CD95-Fc fusion proteins |
| 08/30/2011 | US8007805 Chimeric antigens for breaking host tolerance to foreign antigens |
| 08/30/2011 | US8007804 Complement receptor 2 targeted complement modulators |
| 08/30/2011 | US8007799 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/30/2011 | US8007798 Treatment of complement-associated disorders |
| 08/30/2011 | US8007792 Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
| 08/30/2011 | US8007781 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
| 08/30/2011 | US8007774 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
| 08/30/2011 | US8007770 Purified linear polypeptide epitopes from walnuts and associated methods |
| 08/30/2011 | US8007592 Plants with increased activity of a starch phosphorylating enzyme |
| 08/30/2011 | CA2491872C Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants |
| 08/30/2011 | CA2436407C Polymer conjugates of neublastin and methods of using same |
| 08/30/2011 | CA2425145C Methods of treatment using wisp polypeptides |
| 08/30/2011 | CA2361534C Alpha-conotoxin peptides |
| 08/30/2011 | CA2283630C Ligand/lytic peptide compositions and methods of use |
| 08/30/2011 | CA2190473C Recombinant papilloma virus l1 |
| 08/30/2011 | CA2174429C Transgenic animals harboring app allele having swedish mutation |
| 08/25/2011 | WO2011103584A2 Novel ctla4-ig immunoadhesins |
| 08/25/2011 | WO2011103325A1 Methods for preparing human growth hormone |
| 08/25/2011 | WO2011103248A2 AXMI221z, AXMI222z, AXMI223z, AXMI224z, AND AXMI225z DELTA-ENDOTOXIN GENES AND METHODS FOR THEIR USE |
| 08/25/2011 | WO2011103247A2 Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, and axmi231 delta-endotoxin genes and methods for their use |
| 08/25/2011 | WO2011103242A1 Neuregulin antagonists and use thereof in treating cancer |
| 08/25/2011 | WO2011103185A1 Human group p immunodeficiency virus and uses thereof |
| 08/25/2011 | WO2011103172A1 Compositions and methods for the detection of antibodies to native human leukocyte antigen |
| 08/25/2011 | WO2011103164A1 Monkey homolog of human interferon omega |
| 08/25/2011 | WO2011103105A1 Fibronectin based scaffold domain proteins that bind il-23 |
| 08/25/2011 | WO2011103076A1 Hsa-related compositions and methods of use |
| 08/25/2011 | WO2011102860A1 Rage fusion protein compositions and methods of use |
| 08/25/2011 | WO2011102845A1 Rage fusion protein compositions and methods of use |
| 08/25/2011 | WO2011102796A1 Novel synthetic zinc finger proteins and their spatial design |
| 08/25/2011 | WO2011102394A1 Plant component regulation factor, and use thereof |
| 08/25/2011 | WO2011102363A1 Chemically modified water-soluble elastin, mixed gels of chemically modified water-soluble elastin with collagen and method for producing same |
| 08/25/2011 | WO2011101790A1 Antigenic polypeptides of trichinella and uses thereof |
| 08/25/2011 | WO2011101681A2 Disulphide bond-stabilized functional soluble mhc class ii heterodimers |
| 08/25/2011 | WO2011101457A1 Chimeric surface active proteins |
| 08/25/2011 | WO2011101435A1 Activatable constructs |
| 08/25/2011 | WO2011101332A1 Compositions based on the fibronectin extracellular domain a for the treatment of melanoma |
| 08/25/2011 | WO2011101284A1 Factor viii fusion protein |
| 08/25/2011 | WO2011101277A1 Conjugated proteins |
| 08/25/2011 | WO2011101267A1 Conjugated fviii variants |
| 08/25/2011 | WO2011101242A1 Factor viii molecules with reduced vwf binding |
| 08/25/2011 | WO2011101031A1 A polynucleotide for use in treatment of influenza a virus induced diseases, encoding modified mx protein, said modified mx protein, and a transgenic animal expressing gene encoding modified mx protein |
| 08/25/2011 | WO2011080329A3 Gpav gene resistant to nematodes in the nightshade family |
| 08/25/2011 | WO2011056954A8 Haemophilus parasuis polypeptides and methods of use |
| 08/25/2011 | WO2011053675A3 Improved neurturin molecules |
| 08/25/2011 | WO2011050328A3 Assessment of solid tumor burden |
| 08/25/2011 | WO2011047073A9 Assessing rheumatoid arthritis |
| 08/25/2011 | WO2011003822A3 Aqueous insulin preparations containing methionine |
| 08/25/2011 | WO2010115118A3 Methods for preparing and using multichaperone-antigen complexes |
| 08/25/2011 | WO2010087771A8 Compound and method for treatment of alzheimer's disease |
| 08/25/2011 | US20110209249 Plants having improved growth characteristics and a method for making the same |
| 08/25/2011 | US20110209248 Novel sugar transporters |
| 08/25/2011 | US20110209246 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| 08/25/2011 | US20110207985 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 08/25/2011 | US20110207917 Sam-6 variants, target and methods of use |
| 08/25/2011 | US20110207915 Protein-based material with improved mechanical and barrier properties |